Filing exhibits
- 8-K Current report
- 10.1 License Agreement Between Alexion and Monopar Dated As of October XX, 2024
- 10.2 Common Stock Investment Agreement Between Alexion and Monopar Dated As of October XX, 2024
- 99.1 Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
- Download Excel data file
- View Excel data file
Table of Contents